CoChat

Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Podocyte injury is a major determinant of proteinuric kidney disease and the identification of potential therapeutic targets for preventing podocyte injury has clinical importance. Here, we show that histone deacetylase Sirt6 protects against podocyte injury through epigenetic regulation of Notch signaling. Sirt6 is downregulated in renal biopsies from patients with podocytopathies and its expression correlates with glomerular filtration rate. Podocyte-specific deletion of Sirt6 exacerbates podocyte injury and proteinuria in two independent mouse models, diabetic nephropathy, and adriamycin-induced nephropathy. Sirt6 has pleiotropic protective actions in podocytes, including anti-inflammatory and anti-apoptotic effects, is involved in actin cytoskeleton maintenance and promotes autophagy. Sirt6 also reduces urokinase plasminogen activator receptor expression, which is a key factor for podocyte foot process effacement and proteinuria. Mechanistically, Sirt6 inhibits Notch1 and Notch4 transcription by deacetylating histone H3K9. We propose Sirt6 as a potential therapeutic target for the treatment of proteinuric kidney disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00498-4

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Sirt6 is significantly reduced in podocytes from mice with diabetic nephropathy or ADR nephropathy. a Representative western blot gel documents and summarized data showing the relative protein levels of SIRTs in the kidney from STZ-induced diabetic mice and ADR-treated mice. *P < 0.05 vs. control mice. (n = 8.) b Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in the kidney from diabetic db/db mice and their genetic control db/ + mice. *P < 0.05 vs. db/+ mice. (n = 8.) c Representative confocal microscopic images showing the expression of Sirt6 in podocytes from STZ-induced diabetic mice and ADR-treated mice, synaptopodin were used as podocyte marker. The arrows indicate representative podocytes. Scale bar, 25 μm. d Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in podocytes treated with high glucose (HG, final concentration 20 or 40 mmol/l in medium) for 24 h. *P < 0.05 vs. control. (n = 6.) e Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in podocytes with advanced glycation end-product (AGE, 50–200 μg/ml) for 24 h. *P < 0.05 vs. control. (n = 6.) f Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in podocytes with ADR (ADR, 0.4 μg/ml) for 24 h. *P < 0.05 vs. control. (n = 6.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 1 Sirt6 is significantly reduced in podocytes from mice with diabetic nephropathy or ADR nephropathy. a Representative western blot gel documents and summarized data showing the relative protein levels of SIRTs in the kidney from STZ-induced diabetic mice and ADR-treated mice. *P < 0.05 vs. control mice. (n = 8.) b Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in the kidney from diabetic db/db mice and their genetic control db/ + mice. *P < 0.05 vs. db/+ mice. (n = 8.) c Representative confocal microscopic images showing the expression of Sirt6 in podocytes from STZ-induced diabetic mice and ADR-treated mice, synaptopodin were used as podocyte marker. The arrows indicate representative podocytes. Scale bar, 25 μm. d Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in podocytes treated with high glucose (HG, final concentration 20 or 40 mmol/l in medium) for 24 h. *P < 0.05 vs. control. (n = 6.) e Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in podocytes with advanced glycation end-product (AGE, 50–200 μg/ml) for 24 h. *P < 0.05 vs. control. (n = 6.) f Representative western blot gel documents and summarized data showing the relative protein levels of Sirt6 in podocytes with ADR (ADR, 0.4 μg/ml) for 24 h. *P < 0.05 vs. control. (n = 6.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 2 Downregulation of Sirt6 in renal biopsies from patients with different forms of podocytopathies. a Representative photomicrographs of Sirt6 immunohistochemical staining in human renal cortical tissue from normal subjects (n = 9), patients with focal segmental glomerulosclerosis (FSGS, n = 10), membranous glomerulonephritis (MGN, n = 8), IgA nephropathy (IgA, n = 9); diabetic nephropathy (DN) (n = 8), or diabetic patients without nephropathy (DM-NN). Scale bar: black 100 μm, red 25 μm. (n = 7). b Relative mRNA levels of Sirt6 in the renal biopsies from patients with different forms of podocytopathies. c Positive correlation (Spearman r = 0.5222, P < 0.01) between Sirt6 mRNA levels and estimated glomerular filtration rate (GFR) in all subjects. d Negative correlation (Spearman r = −0.6358, P < 0.01) between Sirt6 mRNA levels and proteinuria in all subjects. *P < 0.05 vs. normal subjects. Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 2 Downregulation of Sirt6 in renal biopsies from patients with different forms of podocytopathies. a Representative photomicrographs of Sirt6 immunohistochemical staining in human renal cortical tissue from normal subjects (n = 9), patients with focal segmental glomerulosclerosis (FSGS, n = 10), membranous glomerulonephritis (MGN, n = 8), IgA nephropathy (IgA, n = 9); diabetic nephropathy (DN) (n = 8), or diabetic patients without nephropathy (DM-NN). Scale bar: black 100 μm, red 25 μm. (n = 7). b Relative mRNA levels of Sirt6 in the renal biopsies from patients with different forms of podocytopathies. c Positive correlation (Spearman r = 0.5222, P < 0.01) between Sirt6 mRNA levels and estimated glomerular filtration rate (GFR) in all subjects. d Negative correlation (Spearman r = −0.6358, P < 0.01) between Sirt6 mRNA levels and proteinuria in all subjects. *P < 0.05 vs. normal subjects. Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 3 Establishment of podocyte-specific Sirt6 knockout (Cre + /Sirt6 fl/fl) mice. a Generation of conditional knockout mice in which Sirt6 is specifically ablated in podocytes by using Cre–LoxP recombination system. Exon 2 and 3 are deleted upon NPHS2-Cre-mediated recombination. Genotyping was confirmed by tail preparation and PCR at 2 weeks of age. b Podocyte-specific loss of Sirt6 was confirmed by immunofluorescent staining of Sirt6 in podocytes, synaptopodin was used as a podocyte marker. The arrows indicate representative podocytes. Scale bar, 25 μm. c Representative western blot gel documents and summarized data showing the decreased expression of Sirt6 in isolated glomeruli from podocyte-specific Sirt6 knockout (Cre + /Sirt6 fl/fl) mice. d UACR (urine albumin-to-creatinine ratio) in mice at different age. e Photomicrographs and quantifications showing typical glomerular structures in mice at different age. Scale bar: black 50 μm, red 25 μm. f Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice at different age by transmission electron microscopy (TEM) analyses. Scale bar, 2 μm. Podocyte-specific Sirt6 knockout mice: Cre + /Sirt6 fl/fl mice; Mice with two WT alleles and Cre expression (Cre + /Sirt6 +/+) were used as controls. *P < 0.05 vs. control (Cre + /Sirt6 +/+ mice). (n = 8.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 3 Establishment of podocyte-specific Sirt6 knockout (Cre + /Sirt6 fl/fl) mice. a Generation of conditional knockout mice in which Sirt6 is specifically ablated in podocytes by using Cre–LoxP recombination system. Exon 2 and 3 are deleted upon NPHS2-Cre-mediated recombination. Genotyping was confirmed by tail preparation and PCR at 2 weeks of age. b Podocyte-specific loss of Sirt6 was confirmed by immunofluorescent staining of Sirt6 in podocytes, synaptopodin was used as a podocyte marker. The arrows indicate representative podocytes. Scale bar, 25 μm. c Representative western blot gel documents and summarized data showing the decreased expression of Sirt6 in isolated glomeruli from podocyte-specific Sirt6 knockout (Cre + /Sirt6 fl/fl) mice. d UACR (urine albumin-to-creatinine ratio) in mice at different age. e Photomicrographs and quantifications showing typical glomerular structures in mice at different age. Scale bar: black 50 μm, red 25 μm. f Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice at different age by transmission electron microscopy (TEM) analyses. Scale bar, 2 μm. Podocyte-specific Sirt6 knockout mice: Cre + /Sirt6 fl/fl mice; Mice with two WT alleles and Cre expression (Cre + /Sirt6 +/+) were used as controls. *P < 0.05 vs. control (Cre + /Sirt6 +/+ mice). (n = 8.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 4 Podocyte-specific loss of Sirt6 exacerbates podocyte injury and proteinuria in DN. a UACR (urine albumin-to-creatinine ratio) in different groups of mice. b Photomicrographs and quantifications showing typical glomerular structure changes in different groups of mice. Scale bar: black 50 μm, red 25 μm. c Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice at different age by transmission electron microscopy (TEM) analyses. Scale bar, 3 μm. d Representative confocal microscopic images showing the expressions of nephrin and podocin in the kidney from different groups of mice. Scale bar, 25 μm. e Representative confocal microscopic images showing the expressions of uPAR in podocytes from different groups of mice. Scale bar, 25 μm. Podocyte-specific Sirt6 knockout mice: Cre + /Sirt6 fl/fl mice; Mice with two WT alleles and Cre expression (Cre + /Sirt6 +/+) were used as controls. *P < 0.05 vs. control (Cre + /Sirt6 +/+ mice), # P < 0.05 vs. Cre + /Sirt6 +/+ STZ mice. (n = 8.) Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 4 Podocyte-specific loss of Sirt6 exacerbates podocyte injury and proteinuria in DN. a UACR (urine albumin-to-creatinine ratio) in different groups of mice. b Photomicrographs and quantifications showing typical glomerular structure changes in different groups of mice. Scale bar: black 50 μm, red 25 μm. c Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice at different age by transmission electron microscopy (TEM) analyses. Scale bar, 3 μm. d Representative confocal microscopic images showing the expressions of nephrin and podocin in the kidney from different groups of mice. Scale bar, 25 μm. e Representative confocal microscopic images showing the expressions of uPAR in podocytes from different groups of mice. Scale bar, 25 μm. Podocyte-specific Sirt6 knockout mice: Cre + /Sirt6 fl/fl mice; Mice with two WT alleles and Cre expression (Cre + /Sirt6 +/+) were used as controls. *P < 0.05 vs. control (Cre + /Sirt6 +/+ mice), # P < 0.05 vs. Cre + /Sirt6 +/+ STZ mice. (n = 8.) Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 5 Sirt6 reduces inflammatory responses, apoptosis and was essential for maintaining basal autophagy in podocytes with HG treatment: a Representative western blot gel documents and summarized data showing the relative protein level of Sirt6 by an Sirt6-adenovirus transfection. b The levels of pro-inflammatory mediators in podocytes with different treatments. c Podocytes with different treatments were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI), and analyzed by flow cytometry to evaluate the role of Sirt6 in the prevention of apoptosis. Quantification of the apoptotic cells was showed at right panel. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment. (n = 6). d Representative confocal microscopic images showing that actin cytoskeleton derangement as evidenced by the loss of actin filaments and a granular cytoplasmic pattern of actin was ameliorated by overexpression of Sirt6. Scale bar, 40 μm. e Representative western blot gel documents and summarized data showing the relative protein levels of autophagy-associated proteins in podocytes with different treatments. f Representative images of LC3 staining by measurement of fluorescent intensity in podocytes showing LC3 staining in different groups of podocytes infected with RFP-GFP-LC3 adenovirus for 24 h. Scale bar, 20 μm. g Representative electronic micrographs and summarized data showing the number of autophagosomes/cell in different groups (a random number of 30 cells were selected for each group) including HG-treated podocytes with or without Sirt6 overexpression. The arrows indicate autophagosomes. Scale bar, 1 μm. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment. (n = 6.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 5 Sirt6 reduces inflammatory responses, apoptosis and was essential for maintaining basal autophagy in podocytes with HG treatment: a Representative western blot gel documents and summarized data showing the relative protein level of Sirt6 by an Sirt6-adenovirus transfection. b The levels of pro-inflammatory mediators in podocytes with different treatments. c Podocytes with different treatments were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI), and analyzed by flow cytometry to evaluate the role of Sirt6 in the prevention of apoptosis. Quantification of the apoptotic cells was showed at right panel. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment. (n = 6). d Representative confocal microscopic images showing that actin cytoskeleton derangement as evidenced by the loss of actin filaments and a granular cytoplasmic pattern of actin was ameliorated by overexpression of Sirt6. Scale bar, 40 μm. e Representative western blot gel documents and summarized data showing the relative protein levels of autophagy-associated proteins in podocytes with different treatments. f Representative images of LC3 staining by measurement of fluorescent intensity in podocytes showing LC3 staining in different groups of podocytes infected with RFP-GFP-LC3 adenovirus for 24 h. Scale bar, 20 μm. g Representative electronic micrographs and summarized data showing the number of autophagosomes/cell in different groups (a random number of 30 cells were selected for each group) including HG-treated podocytes with or without Sirt6 overexpression. The arrows indicate autophagosomes. Scale bar, 1 μm. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment. (n = 6.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 6 Sirt6 modulates Notch signaling by deacetylating H3K9ac at promoters of Notch1 and Notch4. a Representative photomicrographs of H3K9ac immunohistochemical staining in human renal tissue from normal subjects and patients with focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Scale bar: black 100 μm, red 25 μm. b Representative confocal microscopic images showing the levels of H3K9ac in podocytes of the kidney from different groups of mice, synaptopodin was used as a podocyte marker. Scale bar, 25 μm. c Representative western blot gel documents and summarized data showing the effect of overexpression Sirt6 on the levels of H3K9ac in podocytes treated with high glucose (HG, final concentration 40 mmol/l in medium) for 24 h. d Representative heatmap of gene expression levels by multiplex quantitative RT-PCR array. e Summarized data showing the effect of Sirt6 on the mRNA levels of Notch genes in podocytes treated with HG. f Chromatin immunoprecipitation (ChIP) analysis showing the acetylation levels of H3K9 (H3K9ac) in the promoters of Notch1 and Notch4 using antibodies to H3K9ac. g ChIP analysis showed that Sirt6 bound to promoters of Notch1 and Notch4 genes by using antibodies to Sirt6 in podocytes. Sirt6 was dissociated from the promoters of these genes in podocytes with HG treatment and recruited to them after overexpression of Sirt6. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment. (n = 6.) h Summarized data showing the effect of overexpression of Sirt6 or inhibition of Notch signaling by DAPT on the mRNA levels of Notch downstream genes HES1 and Snail1in podocytes treated with HG. i Representative western blot gel documents and summarized data showing Sirt6 deficiency on the effect of Notch1 and Notch4 expressions in podocytes. *P < 0.05 vs. control. (n = 6.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 6 Sirt6 modulates Notch signaling by deacetylating H3K9ac at promoters of Notch1 and Notch4. a Representative photomicrographs of H3K9ac immunohistochemical staining in human renal tissue from normal subjects and patients with focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Scale bar: black 100 μm, red 25 μm. b Representative confocal microscopic images showing the levels of H3K9ac in podocytes of the kidney from different groups of mice, synaptopodin was used as a podocyte marker. Scale bar, 25 μm. c Representative western blot gel documents and summarized data showing the effect of overexpression Sirt6 on the levels of H3K9ac in podocytes treated with high glucose (HG, final concentration 40 mmol/l in medium) for 24 h. d Representative heatmap of gene expression levels by multiplex quantitative RT-PCR array. e Summarized data showing the effect of Sirt6 on the mRNA levels of Notch genes in podocytes treated with HG. f Chromatin immunoprecipitation (ChIP) analysis showing the acetylation levels of H3K9 (H3K9ac) in the promoters of Notch1 and Notch4 using antibodies to H3K9ac. g ChIP analysis showed that Sirt6 bound to promoters of Notch1 and Notch4 genes by using antibodies to Sirt6 in podocytes. Sirt6 was dissociated from the promoters of these genes in podocytes with HG treatment and recruited to them after overexpression of Sirt6. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment. (n = 6.) h Summarized data showing the effect of overexpression of Sirt6 or inhibition of Notch signaling by DAPT on the mRNA levels of Notch downstream genes HES1 and Snail1in podocytes treated with HG. i Representative western blot gel documents and summarized data showing Sirt6 deficiency on the effect of Notch1 and Notch4 expressions in podocytes. *P < 0.05 vs. control. (n = 6.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 7 Inhibition of the Notch pathway rescues the functional defect in Sirt6-deficient podocytes. a The relative levels of pro-inflammatory mediators in podocytes with different treatments. b Summarized data showing the level of podocyte apoptosis determined by flow cytometric analysis in podocytes with different treatments. Podocytes were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI), and analyzed by flow cytometry. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment, & P < 0.05 vs. siRNA-transfected podocytes. (n = 6.) c Representative confocal microscopic images showing that actin cytoskeleton derangement as evidenced by the loss of actin filaments and a granular cytoplasmic pattern of actin was ameliorated by DAPT with different treatments. Scale bar, 40 μm. d Representative western blot gel documents and summarized data showing that gene silencing of Notch1 restored the expressions of nephrin and podocin in Sirt6-deficient podocytes (n = 6). e Representative western blot gel documents and summarized data showing that gene silencing of Notch1 rescued the autophagy defect in Sirt6-deficient podocytes (n = 6). f Representative images of LC3 staining by measurement of fluorescent intensity in podocytes showing LC3 staining in different groups of podocytes infected with RFP-GFP-LC3 adenovirus for 24 h. Scale bar, 20 μm. *P < 0.05 vs. si-negative control, # P < 0.05 vs. si-Sirt6 transfected podocytes. (n = 6.) Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 7 Inhibition of the Notch pathway rescues the functional defect in Sirt6-deficient podocytes. a The relative levels of pro-inflammatory mediators in podocytes with different treatments. b Summarized data showing the level of podocyte apoptosis determined by flow cytometric analysis in podocytes with different treatments. Podocytes were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI), and analyzed by flow cytometry. *P < 0.05 vs. control, # P < 0.05 vs. scramble of HG treatment, & P < 0.05 vs. siRNA-transfected podocytes. (n = 6.) c Representative confocal microscopic images showing that actin cytoskeleton derangement as evidenced by the loss of actin filaments and a granular cytoplasmic pattern of actin was ameliorated by DAPT with different treatments. Scale bar, 40 μm. d Representative western blot gel documents and summarized data showing that gene silencing of Notch1 restored the expressions of nephrin and podocin in Sirt6-deficient podocytes (n = 6). e Representative western blot gel documents and summarized data showing that gene silencing of Notch1 rescued the autophagy defect in Sirt6-deficient podocytes (n = 6). f Representative images of LC3 staining by measurement of fluorescent intensity in podocytes showing LC3 staining in different groups of podocytes infected with RFP-GFP-LC3 adenovirus for 24 h. Scale bar, 20 μm. *P < 0.05 vs. si-negative control, # P < 0.05 vs. si-Sirt6 transfected podocytes. (n = 6.) Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 8 ADR-treated Podocin-Cre Sirt6 fl/fl mice exhibites substantial podocyte injury and glomerulosclerosis. a UACR (urinary albumin-to-creatinine ratio) in different groups of mice. b Photomicrographs and quantifications showing typical changes in glomerular structure in different groups of mice. Scale bar: black 100 μm, red 25 μm. c Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice. Scale bar, 3 μm. d Representative confocal microscopic images showing the expressions of nephrin and podocin in podocytes of the kidney from different groups of mice. Scale bar, 25 μm. Podocyte-specific Sirt6 knockout mice: Cre + /Sirt6 fl/fl mice; Mice with two WT alleles and Cre expression (Cre + /Sirt6 +/+) were used as controls. *P < 0.05 vs. control (Cre + /Sirt6 +/+ mice), # P < 0.05 vs. Cre + /Sirt6 +/+ ADR mice. (n = 8.) e Podocytes with different treatments were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI), and analyzed by flow cytometry. Summarized data showing podocyte apoptosis determined by flow cytometric analysis in podocytes with different treatments. f ChIP analysis showing the acetylation levels of H3K9 (H3K9ac) in the promoters of Notch1 and Notch4 using antibodies to H3K9ac. g ChIP analysis showed that Sirt6 bound to promoters of Notch1 and Notch4 genes by using antibodies to Sirt6 in podocytes. h Summarized data showing the effect of Sirt6 on the mRNA levels of Notch1 and Notch4 genes in podocytes treated with ADR. *P < 0.05 vs. control, # P < 0.05 vs. scramble of ADR treatment. (n = 6.) Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 8 ADR-treated Podocin-Cre Sirt6 fl/fl mice exhibites substantial podocyte injury and glomerulosclerosis. a UACR (urinary albumin-to-creatinine ratio) in different groups of mice. b Photomicrographs and quantifications showing typical changes in glomerular structure in different groups of mice. Scale bar: black 100 μm, red 25 μm. c Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice. Scale bar, 3 μm. d Representative confocal microscopic images showing the expressions of nephrin and podocin in podocytes of the kidney from different groups of mice. Scale bar, 25 μm. Podocyte-specific Sirt6 knockout mice: Cre + /Sirt6 fl/fl mice; Mice with two WT alleles and Cre expression (Cre + /Sirt6 +/+) were used as controls. *P < 0.05 vs. control (Cre + /Sirt6 +/+ mice), # P < 0.05 vs. Cre + /Sirt6 +/+ ADR mice. (n = 8.) e Podocytes with different treatments were stained with fluorescein isothiocyanate (FITC)-conjugated Annexin V and propidium iodide (PI), and analyzed by flow cytometry. Summarized data showing podocyte apoptosis determined by flow cytometric analysis in podocytes with different treatments. f ChIP analysis showing the acetylation levels of H3K9 (H3K9ac) in the promoters of Notch1 and Notch4 using antibodies to H3K9ac. g ChIP analysis showed that Sirt6 bound to promoters of Notch1 and Notch4 genes by using antibodies to Sirt6 in podocytes. h Summarized data showing the effect of Sirt6 on the mRNA levels of Notch1 and Notch4 genes in podocytes treated with ADR. *P < 0.05 vs. control, # P < 0.05 vs. scramble of ADR treatment. (n = 6.) Data are expressed as means ± SE. One-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 9 In vivo overexpression of Sirt6 by intrarenal lentiviral gene delivery ameliorates renal injury in Cre + /Sirt6 fl/fl mice with ADR nephropathy. a The relative mRNA levels of Sirt6 in isolated glomeruli at 5-week after pGLV3-Sirt6 delivered into the mouse kidney by means of intraparenchymal injections. b UACR (urine albumin-to creatinine ratio) in different groups of mice. c Photomicrographs and quantifications showing typical changes in glomerular structure in different groups of mice. Scale bar: black 50 μm, red 25 μm. d Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice. Scale bar, 2 μm. e Representative confocal microscopic images showing the expressions of nephrin and podocin in podocytes from different groups of mice. Scale bar, 25 μm. f ChIP analysis showing the acetylation levels of H3K9 (H3K9ac) in the promoter of Notch1 using antibodies to H3K9ac in isolated glomeruli. g ChIP analysis showed that Sirt6 bound to promoters of Notch1 by using antibodies to Sirt6 in isolated glomeruli. *P < 0.05 vs. control (vector/Cre +/Sirt6 +/+ mice), # P < 0.05 vs. vector/ADR/Cre +/Sirt6 +/+ mice, & P < 0.05 vs. vector/ADR/Cre +/Sirt6 fl/fl mice. (n = 8.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or more
Fig. 9 In vivo overexpression of Sirt6 by intrarenal lentiviral gene delivery ameliorates renal injury in Cre + /Sirt6 fl/fl mice with ADR nephropathy. a The relative mRNA levels of Sirt6 in isolated glomeruli at 5-week after pGLV3-Sirt6 delivered into the mouse kidney by means of intraparenchymal injections. b UACR (urine albumin-to creatinine ratio) in different groups of mice. c Photomicrographs and quantifications showing typical changes in glomerular structure in different groups of mice. Scale bar: black 50 μm, red 25 μm. d Representative photomicrographs and quantifications of mean glomerular basement membrane (GBM) thickness, mean foot process width, and the number of foot processes in different groups of mice. Scale bar, 2 μm. e Representative confocal microscopic images showing the expressions of nephrin and podocin in podocytes from different groups of mice. Scale bar, 25 μm. f ChIP analysis showing the acetylation levels of H3K9 (H3K9ac) in the promoter of Notch1 using antibodies to H3K9ac in isolated glomeruli. g ChIP analysis showed that Sirt6 bound to promoters of Notch1 by using antibodies to Sirt6 in isolated glomeruli. *P < 0.05 vs. control (vector/Cre +/Sirt6 +/+ mice), # P < 0.05 vs. vector/ADR/Cre +/Sirt6 +/+ mice, & P < 0.05 vs. vector/ADR/Cre +/Sirt6 fl/fl mice. (n = 8.) Data are expressed as means ± SE. Student’s t-test was employed for comparisons between two groups; one-way ANOVA followed by Tukey’s post-test for multiple comparisons was used for groups of three or moreCC BY · PubMed Central
Fig. 10 Schematic depicting Sirt6 deficiency exacerbates podocyte injuries and proteinuria through targeting Notch signaling. Under normal conditions, SIRT6 inhibits the transcription of Notch1 and Notch4 genes by decreasing H3K9ac levels in the promoter region of Notch1 and Notch4. Under pathological conditions, SIRT6 reduction leads to the increased levels of H3K9ac in the promoters of Notch1 and Notch4, thereby enhancing the transcription of Notch1 and Notch4 gene. The activation of Notch signaling finally results in podocyte injury through inducing inflammation, apoptosis, actin cytoskeleton derangement, as well as the inhibition of autophagy
Fig. 10 Schematic depicting Sirt6 deficiency exacerbates podocyte injuries and proteinuria through targeting Notch signaling. Under normal conditions, SIRT6 inhibits the transcription of Notch1 and Notch4 genes by decreasing H3K9ac levels in the promoter region of Notch1 and Notch4. Under pathological conditions, SIRT6 reduction leads to the increased levels of H3K9ac in the promoters of Notch1 and Notch4, thereby enhancing the transcription of Notch1 and Notch4 gene. The activation of Notch signaling finally results in podocyte injury through inducing inflammation, apoptosis, actin cytoskeleton derangement, as well as the inhibition of autophagyCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 343

Metadata

Authors
Liu, M., Liang, K., Zhen, J., Zhou, M., Wang, X., Wang, Z., Wei, X., Zhang, Y., Sun, Y., Zhou, Z., Su, H., Zhang, C., Li, N., Gao, C., Peng, J., & Yi, F.
Affiliations
  • Shandong University (CN)
  • Huazhong University of Science and Technology (CN)
  • Virginia Commonwealth University (US)
Corresponding author
Yi, Fan
Venue
Nature Communications
Published
2017-09-04
Volume
8
Issue
1
Pages
413-413
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2752265698
Cited by
343
References
52
Citations by year
2026: 22 · 2025: 40 · 2024: 47 · 2023: 51 · 2022: 56 · 2021: 49 · 2020: 39 · 2019: 26 · 2018: 13
FWCI
19.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (81400730, 81600570, 81470958, 91642204, 81371317, 81525005)
  • National Science Fund for Distinguished Young Scholars (81525005)
Topics
  • Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
SIRT6, podocyte injury, proteinuria, Notch signaling, Notch1, Notch4, histone deacetylase, epigenetic regulation, diabetic nephropathy, adriamycin nephropathy, uPAR, actin cytoskeleton, autophagy, podocyte apoptosis, podocytopathy, glomerular filtration barrier
MeSH terms
Acetylation, Animals, Autophagy, Biopsy, Diabetes Mellitus, Experimental, Diabetic Nephropathies, Doxorubicin, Histones, Humans, Inflammation, Kidney, Lysine, Male, Promoter Regions, Genetic, Proteinuria, Signal Transduction, Down-Regulation, Apoptosis, Gene Deletion, Mice, Knockout, Integrases, Sirtuins, Podocytes, Rats, Receptors, Notch

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. https://app.cochat.ai/papers/10.1038/s41467-017-00498-4
The paper
Liu, M., Liang, K., Zhen, J., Zhou, M., Wang, X., Wang, Z., Wei, X., Zhang, Y., Sun, Y., Zhou, Z., Su, H., Zhang, C., Li, N., Gao, C., Peng, J., & Yi, F. (2017). Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nature Communications. https://doi.org/10.1038/s41467-017-00498-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.